NAACCR Item #3820: CEA Pretreatment Lab Value
Padding Character' '
|Item #||Length||Source of Standard||Year Implemented||Version Implemented||Year Retired||Version Retired||Column #|
|3820||6||NAACCR||2018||18||1790 - 1795|
NAACCR XML: Tumor.ceaPretreatmentLabValue
CEA (Carcinoembryonic Antigen) Pretreatment Lab Value records the CEA value prior to treatment. CEA is a nonspecific tumor marker that has prognostic significance for colon and rectum cancer.
CEA (Carcinoembryonic Antigen) Pretreatment Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Colon and Rectum, CS SSF# 3.
|0.0||0.0 nanograms/milliliter (ng/m) exactly|
(Exact value to nearest tenth in ng/ml)
|XXXX.1||10,000 ng/ml or greater|
|XXXX.7||Test ordered, results not in chart|
|XXXX.8||Not applicable: Information not collected for this case
(If this information is required by your standard setter, use of code XXXX.8 may result in an edit error.)
|XXXX.9||Not documented in medical record
CEA (Carcinoembryonic Antigen) Pretreatment Lab Value not assessed or unknown if assessed
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.